TrialAntimicrobial agents and chemotherapy2014

Efficacy and safety of danoprevir-ritonavir plus peginterferon alfa-2a-ribavirin in hepatitis C virus genotype 1 prior null responders.

Edward J Gane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.